Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOS
NCT05294900Phase 2Completed
- Sponsor
- Yonsei University
- Start
- May 2023
- Primary completion
- Oct 2025
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, carboplatin in head and neck squamous cell carcinoma (HNSCC), sponsored by Yonsei University. Started May 2023; status: completed.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT05294900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05294900.